Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.76
-0.01 (-0.74%)
At close: May 01, 2025, 3:59 PM
0.78
3.04%
After-hours: May 01, 2025, 06:16 PM EDT
Xilio Therapeutics Revenue
Xilio Therapeutics reported an annual revenue of $6.34M, reflecting a 0% growth. For the quarter ending December 31, 2024, Xilio Therapeutics generated $1.72M in revenue.
Revenue (ttm)
$6.34M
Revenue Growth
0%
Price / Sales Ratio
8.06
Revenue / Employee
$99.13K
Employees
64
Market Cap
39.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 6.34M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |